Ophthalmology Times - Ophthalmology news, articles, and events

ASCRS 2025: Maanasa Indaram, MD, offers guidance for general anesthesia in pediatric corneal crosslinking

The retrospective study assessed corneal cross-linking complications at Wills Eye Hospital from 2018 to 2023.

Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting

Regeneron to highlight real-world efficacy of aflibercept 8 mg (EYLEA HD) in wAMD, DME, and DR

By Martin David Harp

Human papillomavirus possibly linked to thyroid eye disease

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting from May 4 to 8 in Salt Lake City.

By Lynda Charters

ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases

New research links HPV to thyroid eye disease, suggesting viral infection may trigger immune responses through molecular mimicry, impacting diagnosis and treatment.

(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases

By Taylor Strange, DO
Sheryl Stevenson

ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system

Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.

By Neda Shamie, MD
Sheryl Stevenson

Red light therapy in children with myopia

By Lynda Charters

ASCRS 2025: A museum exhibit inspired an award-winning alternative to traditional blepharoplasty

Chinese researchers reveal that low-level red light therapy may control myopia in children but raises concerns about retinal damage and cone density reduction.

$Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting$

ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery

Patricia Buehler, MD, MPH, presented a poster and two patient films at the ASCRS annual meeting, focused on minimally-invasive blepharoplasty device Ziplyft (Osheru).

$(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery$

By Bonnie An Henderson, MD
Sheryl Stevenson

ASCRS 2025: Rotational stability and outcomes with 'monofocal plus' toric IOL with Gregory Moloney, FRANZCO, FRCSC

AI’s use in diagnostic tools, surgical guidance, and its ethical considerations in ophthalmology are transforming the field

(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability

By Gregory Moloney, FRANZCO, FRCSC
Sheryl Stevenson

ASCRS 2025: A UK study demonstrates the benefit of endoscopic cyclophotocoagulation for patients with POAG and cataracts

A study reports minimal rotation and improved near vision following implantation of the Eyhance toric lens.

Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.

ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL

Sheng Lim, MD, FRCOphth, discussed the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP.

By Steven J. Dell, MD
Sheryl Stevenson

ASCRS 2025: Near vision victories and distance vision surprises with a presbyopia-correcting IOL

Data show excellent refractive stability, strong visual acuity across all distances, and contrast sensitivity comparable to monofocal IOLs.

$Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting$

By Hattie Hayes

Allotex appoints Michael Mrochen as CEO

Alex Hacopian, MD, speaks about patient-reported outcomes from a presbyopia-correcting IOL at the 2025 ASCRS annual meeting.

By Sydney M Crago

Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery

Allotex launches its innovative eye implant for near vision restoration, appointing Michael Mrochen as CEO to drive global expansion and market access.

$Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery$

By Sheryl Stevenson

NIH researchers use AI to enhance retinal imaging

George O. Waring IV, MD, FACS, discusses the “vision for a lifetime” approach and how modern advancements allow tailored treatments for every stage of eye maturity.

By Sydney M Crago